Zydus Lifesciences bags USFDA nods for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and Dexamethasone Tablets USP, 2 mg Ruchika Sharma9 Feb 2024 11:55 AM ISTAhmedabad: Zydus Lifesciences Limited has received final approvals from the United States Food and Drug Administration (USFDA) to manufacture and...
Zydus Lifesciences bags USFDA nod for Gabapentin Tablets (Once-Daily) for Postherpetic Neuraligia management Ruchika Sharma27 Jan 2024 11:44 AM ISTFollowing approval, the product will be launched immediately in the US.
Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market Ruchika Sharma19 Jan 2024 3:30 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered...
Zydus Lifesciences secures USFDA nod for Pimavanserin capsules, tablets Ruchika Sharma18 Jan 2024 11:40 AM ISTBoth the tablets and the capsules will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Zydus Healthcare gets Rs 284.58 crore income tax demand notice Ruchika Sharma27 Dec 2023 3:29 PM ISTThe demand is determined due to "apparent mistakes while processing its return of income', it said.
USFDA issues 6 observations for Zydus Lifesciences Ahmedabad facility Ruchika Sharma23 Dec 2023 11:30 AM ISTAhmedabad: Zydus Lifesciences has announced that the U.S. Food and Drug Administration (USFDA) has closed the inspection with 6...
Zydus Lifesciences gets USFDA nod to begin Phase II clinical trial of ZYIL1 in Parkinson's disease patients Ruchika Sharma18 Dec 2023 12:30 PM ISTZydus has been granted an 'Orphan Drug Designation' by the US FDA for ZYIL1 in treatment of patients with CAPS, a rare auto-inflammatory disease.
Seizure drug: Zydus Lifesciences gets USFDA approval for Lacosamide tablets Ruchika Sharma16 Dec 2023 12:45 PM ISTThe product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad.
Zydus Lifesciences bags USFDA nod for HIV-1 drug Darunavir Ruchika Sharma15 Dec 2023 3:00 PM ISTDarunavir must be -co-administered with Ritonavir and with other antiretroviral agents.
USFDA nod to Zydus Lifesciences cancer drug Cyclophosphamide Ruchika Sharma14 Dec 2023 3:24 PM ISTCyclophosphamide is a chemotherapy medication that slows the growth of cancer cells.
Zydus Lifesciences gets USFDA okay for acquired methemoglobinemia injection Methylene Blue Ruchika Sharma6 Dec 2023 3:30 PM ISTMethylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia.
Zydus Lifesciences gets USFDA nod for heart failure drug Ivabradine Ruchika Sharma1 Dec 2023 2:36 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
